AGL 40.28 Increased By ▲ 0.28 (0.7%)
AIRLINK 127.08 Increased By ▲ 0.04 (0.03%)
BOP 6.62 Decreased By ▼ -0.05 (-0.75%)
CNERGY 4.48 Decreased By ▼ -0.03 (-0.67%)
DCL 8.60 Increased By ▲ 0.05 (0.58%)
DFML 41.72 Increased By ▲ 0.28 (0.68%)
DGKC 87.40 Increased By ▲ 0.55 (0.63%)
FCCL 32.45 Increased By ▲ 0.17 (0.53%)
FFBL 64.99 Increased By ▲ 0.19 (0.29%)
FFL 10.23 Decreased By ▼ -0.02 (-0.2%)
HUBC 109.48 Decreased By ▼ -0.09 (-0.08%)
HUMNL 14.65 Decreased By ▼ -0.03 (-0.2%)
KEL 5.07 Increased By ▲ 0.02 (0.4%)
KOSM 7.64 Increased By ▲ 0.18 (2.41%)
MLCF 41.38 No Change ▼ 0.00 (0%)
NBP 59.50 Decreased By ▼ -0.91 (-1.51%)
OGDC 192.40 Increased By ▲ 2.30 (1.21%)
PAEL 28.15 Increased By ▲ 0.32 (1.15%)
PIBTL 7.75 Decreased By ▼ -0.08 (-1.02%)
PPL 151.00 Increased By ▲ 0.94 (0.63%)
PRL 26.22 Decreased By ▼ -0.66 (-2.46%)
PTC 16.15 Increased By ▲ 0.08 (0.5%)
SEARL 83.11 Decreased By ▼ -2.89 (-3.36%)
TELE 7.78 Increased By ▲ 0.07 (0.91%)
TOMCL 35.38 Decreased By ▼ -0.03 (-0.08%)
TPLP 8.10 Decreased By ▼ -0.02 (-0.25%)
TREET 16.02 Decreased By ▼ -0.39 (-2.38%)
TRG 53.10 Decreased By ▼ -0.19 (-0.36%)
UNITY 26.28 Increased By ▲ 0.12 (0.46%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 9,985 Increased By 101.4 (1.03%)
BR30 31,147 Increased By 547.3 (1.79%)
KSE100 94,168 Increased By 813 (0.87%)
KSE30 29,173 Increased By 242.3 (0.84%)

ISLAMABAD: The Special Assistant to the Prime Minister (SAPM) on National Health Services, Dr Faisal Sultan, on Thursday said the Chinese made Covid-19 vaccine, Sinopharm, was not recommended for the people above 60 years of age.

Talking to reporters here after inaugurating three initiatives including the National Health Laboratory (NHL), the Global Health Security Agenda (GHSA) Secretariat, and the Transformation and Excellence Center for Health (TECH) aimed at strengthening the country’s public health system, he said that based on the findings of expert committee’s preliminary analysis of Sinopharm data, the government has recommended the vaccine be licensed for people aged 18-60, at this stage. “At this stage, the committee has not recommended the vaccine for people older than 60,” he added.

Dr Sultan said this was not an “unusual” scenario.

“When new medicines come, such things happen and the basis is whether that [age group of the] population or people with certain conditions were included in the research for it. When we get more data, perhaps it will be used for people above 60 as well.”

He said the government was working on health sector reforms agenda to make positive changes in the service delivery system to serve the masses, adding, the NHL would be helpful in strengthening the diseases diagnostic and response system in the country.

Copyright Business Recorder, 2021

Comments

Comments are closed.